drugset / Trial / NCT04298099

Ropivacaine Plasma Concentrations and Pharmacokinetics Following Erector Spinae Plane Block in the Pediatric Population

NCT04298099 ↗

Phase 4 Completed 4 enrolled Baylor College of Medicine
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

The primary aim of this study is to evaluate the pharmacokinetics of serum ropivacaine concentrations following erector spinae plane peripheral nerve blocks in the pediatric population. Secondary outcomes will assess the efficacy of the block with perioperative morphine equivalent consumption and pain scores.

Timeline

Start
2020-12-18
Primary completion
2021-01-27
Completion
2021-03-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.2 % Other
Comparator Ropivacaine Other / unclassified 0.5 % Other

Indications

No indication recorded.